Archive · 8 Jun 2025
UK Issues Warning on Weight-Loss Drugs and Pregnancies
Some women taking weight-loss drugs like Ozempic and Wegovy have become pregnant unexpectedly.
These drugs can boost fertility by helping with weight loss, especially in women with obesity.
The UK's health agency is warning women to use birth control while taking these drugs.
The agency is recommending that women continue to use contraception for up to two months after stopping the medication before trying to get pregnant.
This is because the drugs could affect how birth control works or might be risky during pregnancy.
The drugs are not approved for cosmetic weight loss, and the risks in pregnancy are not fully known, similar weight-loss interventions like surgery have been associated with higher miscarriage rates.
UK health authorities issued a safety alert due to unexpected pregnancies.
The alert is related to weight-loss drugs like Ozempic and Wegovy.
At least 40 cases of unexpected pregnancies have been reported.
These drugs may boost fertility, especially in women with obesity.
Women are advised to use contraception and discuss risks with healthcare providers.
- Who
- British health authorities (MHRA).
- What
- UK warns of unexpected pregnancies linked to weight-loss drugs.
- When
- The MHRA issued a public safety alert on May 6.
- Where
- United Kingdom.
- Why
- To inform women about potential fertility increase and contraceptive risks.
Patients
Medical Experts
Impact on Fertility
Patients
Patients taking the medications are more likely to get pregnant due to increased fertility.
Medical Experts
Medications can increase fertility, especially in obese patients.
- Drugs Mentioned
- Ozempic, Wegovy, Mounjaro, Saxenda
- Active Ingredients
- Semaglutide, Tirzepatide, Liraglutide
- Reports of Pregnancies
- 40
- Agency Issuing Warning
- Medicines and Healthcare products Regulatory Agency (MHRA)
- Drugs and Pregnancy
- Should not be taken during pregnancy or while trying to conceive